Home
Home » companies

OncoGenex

OncoGenex initiates clincal trial of OGX-427

OncoGenex initiates clincal trial of OGX-427
The Fly on the Wall

OncoGenex Loss Lower than Expected

OncoGenex Loss Lower than Expected
Yahoo/Zacks

OncoGenex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript

OncoGenex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha

OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer

OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer
Sacramento Bee, CA

5 Pharmaceutical Companies With Insider Buying During August 14-16

5 Pharmaceutical Companies With Insider Buying During August 14-16
Seeking Alpha

OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427

OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
PharmaLive

3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days

3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days
Seeking Alpha

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters
Pharmalive

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
Bradenton Herald, FL

Cancer-Fighting Biotech OncoGenex Rates a Buy

Cancer-Fighting Biotech OncoGenex Rates a Buy
Minyanville